Novo Halts Work on Cell Therapy Cure for Diabetes to Cut Costs

Novo Nordisk A/S cut its cell therapy division, which has been trying to find a cure for type 1 diabetes, as the Ozempic maker continues to slash headcount to focus on lucrative areas of obesity and diabetes treatment....

Redirecting to full article...